ALKBH3 and squamous cell carcinoma: To validate our findings, we examined whether ALKBH3 gene silencing in vivo affects squamous cell carcinoma using the human lung squamous cell carcinoma cell line RERF-LC-AI, but no significant differences in tumour formation were observed between the two groups injected with either ALKBH3 siRNA or control RNA (data not shown).